Clinical Trials Directory

Trials / Completed

CompletedNCT03424993

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure

Vascular Effects of Dietary Salt in Humans With Salt-Resistant Blood Pressure: Dietary Counseling Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
100 (actual)
Sponsor
University of Delaware · Academic / Other
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the effects of dietary salt restriction on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Detailed description

Cardiovascular disease remains a major Public Health problem and is the leading cause of death in the US. Dietary sodium restriction is considered an important lifestyle modification for individuals with hypertension; however, there is controversy about the effects of dietary salt given that many individuals do not have "salt sensitive" blood pressure. Deleterious effects of salt on the vasculature may explain the finding that chronic DSR reduces the cardiovascular event rate by 25%despite only minor reductions in BP. It is not known whether dietary sodium restriction improves central pulsatile hemodynamics, known to be related to the development of left ventricular hypertrophy and heart failure risk, and whether the hypothesized improvements in central hemodynamics are similar in men \& women. The purpose of this study is to determine the effects of dietary sodium restriction through dietary counseling on central hemodynamics and vascular function in men and women with salt resistant blood pressure.

Conditions

Interventions

TypeNameDescription
OTHERDietary Sodium RestrictionA registered dietician will counsel participants to reduce daily habitual dietary salt intake below 2000mg over 4 weeks
OTHERControlParticipants will consume their routine habitual dietary sodium intake \> 3400mg per day with regular pre determined check in phone calls from a registered dietician.

Timeline

Start date
2018-01-21
Primary completion
2024-06-10
Completion
2024-06-10
First posted
2018-02-07
Last updated
2024-10-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03424993. Inclusion in this directory is not an endorsement.